1Asahara T,Murohara T,Sullivan A. Isolation of putative progenitor endothelial cells for angiogenesis[J].Science,1997.964-976.doi:10.1126/science.275.5302.964.
2Inser J,Asahara T. Angiogenesis and vasculaogensis satherapeutic strategies for postnatal neovascularization[J].Journal of Clinical Investigation,1999,(09):1231-1236.
3Yamamoto K,Kondo T,Suzuki S. Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs:therapeutic effect by stem cell transplantation[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2004.192-196.
4Kalka C,Masuda H,Takahashi T. Transplantation of ex-vivo expanded endothelial progenitor cells for therapeutic neovascularizafion[J].Proceedings of the National Academy of Sciences(USA),2000.3422-3427.
6Dorros G, Jaff MR, Dorros AM, et al. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia:five-year follow-up. Circulation 2001;104(17):2057-62
7Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial Lancet 2002;360(9331):427-35
8Sivan-Loukianova E,Awad OA,Stepanovic V,et al.CD34+blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vasc Res,2003,40(4):368-377.
9Asahara T, Murohara T, Sullivan A. et al. Isolation of putative progenitor endothelial cells for angrogenesis. Science, 1997, 275(5302):964-967.
6Nikeghbalian S, Pournasr B, Aghdami N, et al. Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis. Arch Iran Med. 2011;14(1):12-17.
7Honmou O, Houkin K, Matsunaga T, et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain. 2011 ;134(Pt 6): 1790-1807.
8Connick P, Kolappan M, Crawley C, et al. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol. 2012; 11 (2): 150-156.
9Lu D, Chen B, Liang Z, et al. Comparison of bone marrow mesenchymal stem ceils with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double,blind, randomized, controlled trial. Diabetes Res Clin Pract. 2011;92(1):26-36.
10Zhao D, Cui D, Wang B, et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012;50(1):325-330.
